openPR Logo
Press release

Anticoagulation Therapy Market-Technological Growth, Trends, Size, Share, Dominated Companies- Pharmaceuticals PLC, Teva Pharmaceutical, Pfizer, Sanofi, Hoffmann-La Roche, Fresenius Kabi AG, Aspen Holdings, Johnson & Johnson Services

02-03-2020 11:44 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Anticoagulation Therapy Market

Anticoagulation Therapy Market

A Recent Market Intelligence Report that is published by Data Bridge Market Research on Global Anticoagulation Therapy Market is projected to register a substantial CAGR of 8.3% in the forecast period of 2019 to 2026.

Global "Anticoagulation Therapy Market" report presents a pin-point breakdown of Industry based on type, applications, and research regions. Growth strategies adopted by these companies are studied in detail in the report. The market size section gives the Anticoagulation Therapy market revenues, covering both the historic growth of the market and forecasting the future.

Download Sample Copy of this Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-anticoagulation-therapy-market

About this Anticoagulation Therapy Market: Anticoagulation therapy is a medication used in prevention of blood clots formation and to uphold blood vessels open. Anticoagulants are usually called as blood thinners but in reality it do not thin the blood but only helps to prevent or to reduce blood clot formation/thrombi. There are various anticoagulants available in the market such as vitamin K antagonists, heparin and novel oral anticoagulation which is used for prophylaxis/treatment of various thromboembolic disorders, such as heart attack (myocardial infarction), stroke and deep venous thrombosis (DVT).

Some Of The Major Players Operating In The Global Syringe Market are Hikma Pharmaceuticals PLC, Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis AG, Eisai Co., Ltd., Pfizer Inc., Sanofi, F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Aspen Holdings, Shanghai Fosun Pharmaceutical(Group)Co., Ltd. , Cipla Inc, Johnson & Johnson Services, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, DAIICHI SANKYO COMPANY, LIMITED, Eagle Pharmaceuticals, Inc., Endo Pharmaceuticals Inc, Mitsubishi Tanabe Pharma Corporation, Portola Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd., among others.

Browse Full Report with Details TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-anticoagulation-therapy-market

Global Anticoagulation Therapy Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as company's processes and cost structures are also analyzed in this Anticoagulation Therapy report. This Anticoagulation Therapy Market report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin Anticoagulation Therapy by regions (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) and other regions can be added.

Explore Key Industry Insights in 60 Tables and 29.50 Figures from the 350 Pages of Report, "Global Anticoagulation Therapy Market - Industry Trends & Forecast to 2027".

Segmentation: global anticoagulation therapy market

Global anticoagulation therapy market is segmented into nine notable segments which are treatment, therapeutic class, drug type, route of administration, therapeutic area, procedure, type, end user and distribution channel.

On the basis of treatment, the market is segmented into deep vein thrombosis (dvt), pulmonary embolism (pe), arterial thromboembolism (at), stroke and others

On the basis of therapeutic class, the market is segmented into novel oral anticoagulation (noac), heparin, vitamin k antagonists and others
In july 2015, sandoz ag, a division of novartis ag, launched bivalirudin a generic version of angiomax in 250 mg of single-dose vial. This product launch will help to grow novartis ag product portfolio and the company revenue.

On the basis of drug type, the market is segmented into bivalirudin, dabigatran, edoxaban, betrixaban, rivaroxaban, apixaban, enoxaparin, delteparin and others.

On the basis of route of administration, the market is segmented into oral and injectable
On the basis of therapeutic area, the market is segmented into cardiovascular diseases, oncology, respiratory, nephrology, cns and others
On the basis of procedure, the market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis and heart valve replacement

On the basis of type, the market is segmented into generics and branded

On the basis of end user, the market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others

On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy

Purchase This Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-anticoagulation-therapy-market

The Anticoagulation Therapy Market report highlights the key players and the latest strategies including company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, new product launches, partnerships, joint ventures, product width and breadth, application dominance, technology lifeline curve, segmentation in terms of region and industry competition, profit and loss ratio, and investment ideas.

Product Launch

In November 2018, Daiichi Sankyo Company, Limited launched LIXIANA in Japan. It is a branded version of edoxaban. It is administered to reduce the chance of systemic embolism (SE) and stroke in patients who are having non-valvular atrial fibrillation (NVAF). This product launch will help the company to expand its business in Japan.
In August 2018, Fresenius Kabi launched four new heparin sodium in freeflex containers that is an advanced IVcontainer technology. The major benefits of this product launch will help to expand the portfolio of ready-toadminister and convenient medicines in non-DEHP bags and as well as in prefilled syringes.
In June, 2018, Mylan N.V. has launched Angiomax's generic vesion Bivalirudin in 250 mg single-dose vial in injectable form. This product launch will help company to increase its market share in global anticoagulation therapy.

Global Anticoagulation Therapy Market Report includes Detailed TOC points:

1 Introduction

Objectives Of The Study
Market Definition
Overview Of Global Anticoagulation Therapy Market
Limitations
Markets Covered
2Market Segmentation

1 Markets Covered
2 Geographical Scope
3 Years Considered For The Study
4 Currency And Pricing
5 Dbmr Tripod Data Validation Model
6 Multivariate Modelling
7 Products Lifeline Curve
8 Primary Interviews With Key Opinion Leaders
9 DBMR Market Position Grid
1 Vendor Share Analysis
11 Secondary Sources
12 Assumptions
3 Market Overview

1 Drivers
.....
3.3 Opportunities

3.1 Rising Government Initiatives
3.2 Strategic Initiative By Market Players
3.3 Rise In Awareness Among The Population
3.4 Growing Healthcare Infrastructure
....
4 Executive Summaries

5 Premium Insights

6 Regulatory Procedure

7 Global Anticoagulation Therapy Market, By Type

8 Global Anticoagulation Therapy Market, by disease type

9 Global Anticoagulation Therapy Market, By Deployment

10 Global Anticoagulation Therapy Market, By End User

11 Global Anticoagulation Therapy Market, By Distribution Channel

12 Global Anticoagulation Therapy Market, By Geography

13 Global Anticoagulation Therapy Market, Company Landscape

1 Company Share Analysis: Global
2 Company Share Analysis: North America
3 company share analysis: Europe
4 company share analysis: Asia-Pacific
14 Company Profile

1.1 Company Snapshot
1.2 Revenue Analysis
1.3 Company Share Analysis
1.4 Product Portfolio
1.5 Recent Development
Continued...!!!

Customization of the Report

All segmentation provided above in this report is represented at country level.

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulation Therapy Market-Technological Growth, Trends, Size, Share, Dominated Companies- Pharmaceuticals PLC, Teva Pharmaceutical, Pfizer, Sanofi, Hoffmann-La Roche, Fresenius Kabi AG, Aspen Holdings, Johnson & Johnson Services here

News-ID: 1916604 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Anticoagulation

Anticoagulation Market Rising Demand and Growth Forecast Through 2034
Exactitude Consultancy., Ltd. has published an extensive research report titled "Anticoagulation Market" offering a comprehensive overview of the global Anticoagulation market landscape. This report includes sales volume, pricing analysis, market share, rankings of leading companies, and detailed segmentation by region, country, product type, and application. It also delivers forward-looking forecasts of market size through 2034, based on data from 2020 onward, combined with insights into future market dynamics. In addition to
Anticoagulation Therapy Market Size, Share, Growth and Trends, Report 2024-2031
Anticoagulants, commonly known as blood thinners, are substances that prevent or reduce blood clotting, thereby extending the time it takes for blood to clot. These medications work by targeting different sites in the coagulation pathway, with some having effects at multiple points. For instance, direct thrombin inhibitors and direct factor Xa inhibitors work by blocking the formation of fibrin clots. Other anticoagulation mechanisms include inhibiting vitamin K-dependent factors, which are essential
Advanced Anticoagulation: Navigating the Heparin Market (2023 to 2029)
Heparin Market has valued at US$ 7.23 Bn in 2022. The Heparin Market size is estimated to grow at a CAGR of 1.6% over the forecast period. Heparin Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the "Heparin Market". The report includes key business insights, demand analysis, pricing analysis, and competitive landscape. The report provides the current state of the Heparin Market by
Anticoagulation Market 2023 To Show Startling Growth During Forecast Period 2023 …
Global Anticoagulation Market Size is valued USD 32890.1 million in 2021, is expected to reach USD 56003.6 million by 2028, and grow at a CAGR of 7.9% over the forecast period 2022-2028. The Anticoagulation Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers
Anticoagulation Therapy Market Key Research Insights By Leading Key Players, Opp …
Precision Business Insights published a research report on "Anticoagulation Therapy Market: By Drug Type (Warfarin, Heparin, Novel Oral Anticoagulants, Others), By Route of Administration (Oral, Parenteral), By Application (Therapeutic applications, Laboratory Services), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography- Global/Region/Country Forecast to 2027", Anticoagulation therapy market is anticipated to witness significant market growth during the forecast period 2021-2027. Glance our 200 slides market research and competitive
US Anticoagulation Therapy Market|Key players in the US anticoagulation therapy …
The report "US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022", The US anticoagulation therapy market has witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 8.5% between 2017 and 2022 to reach USD 27.83 Billion by 2022.